LDS/Medical Tests/Transferrin and Transferrin Saturation

Transferrin and Transferrin Saturation

Transferrin is a blood glycoprotein that binds iron and transports it throughout the human body. It binds iron within the gastrointestinal tract and transports it into enterocytes and then to storage cells or to peripheral tissues for immediate use.  In healthy individuals about 20-40% of all of the available sites on the transferrin molecule are occupied. Iron that is bound to transferrin comprises less than 0.1% of the human body’s total iron, the majority being within storage cells in the form of ferritin.

Iron in the ferric form (Fe3+) binds best with transferrin’s two high-affinity binding sites. Transferrin travels within the peripheral circulation until it encounters the transferrin receptor on a cell, whereupon the transferrin will bind to the receptor on the cell surfacel. After binding, transferrin with the iron is transported into the cell inside a vesicle and the pH of the vesicle is reduced at which time the ions will be released from the transferrin. The transferrin molecule is released back to the cell exterior and the transferrin will begin the iron uptake, transport and release cycle over again.

Since transferrin serves as a transporter for iron, in addition to transferrin saturation, iron levels, iron binding capacity (TIBC) and ferritin it could be used for evaluating the cause of anemia. Therefore, it is often ordered with iron and TIBC. Elevated levels of transferrin are seen in iron deficiency anemia, in oral contraceptive consumption, and pregnancy. Decreased levels are seen in disorders associated with increased iron levels such as iron poisoning, hemolytic anemia, hemochromatosis, some malignancies, and chronic infection.

  • Screening for chronic iron overload conditions
  • As an aid in diagnosis of hemochromatosis
  • Transferrin saturation aids diagnsis of iron deficiency anemia
  • In chronic liver disease in conjuction with serum ferritin testing, aids evaluation of iron overloading
  • Diagnosis of iron-deficiency anemai

Increased in:

  • Pregnancy
  • Oral contraceptives
  • Iron deficiency (anemia)
  • Viral hepatitis

Decreased in:

  • Inherited atransferrinemia (rare)
  • Disorders associated with inflammation or necrosis
  • Chronic inflammation or malignancy
  • Generalized malnutrition
  • Nephrotic syndrome
  • Ascorbic acid deficiency
  • Iron overload states such as hemolytic anemia, hemochromatosis, and iron poisoning
  • Thalassemia
  • After treatment for B12 or folate deficiency
Group mg/dL g/L
0–4 days 130–275 1.30–2.75
3 months–16 years 203–360 2.03–3.60
Adults (16–60 years)
Male 215–365 2.15–3.65
Female 250–380 2.50–3.80
60–90 years 190–375 1.90–3.75
>90 years 186–347 1.86–3.47
Maternal (at term), x̄3,4 305 3.05
Adult levels are reached by 9 months.
Turbidimetric.

Serum (SST) or Urine. 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Complete Blood Count, Vitamin B12, Folate, Ferritin, Iron, TIBC, Free erythrocyte porphyrin in children, soluble Transferrin receptor.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Chem. 1992;38:2078. [PMID: 1394993]
  • Clin Biochem Rev. 2010 Feb;31(1):3-8. [PMID: 20179792]
  • Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757